| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 02/20/1990 | US4902673 Enhancing growth of bifidobacteria using soybean extract |
| 02/20/1990 | US4902618 Production of hybridoma antibodies for interferon |
| 02/20/1990 | US4902616 Process for the preparation of capsular polysaccharides of staphylococci, the polysaccharides obtained, uses of these polysaccharides and strains for carrying out of the process |
| 02/20/1990 | US4902615 Diagnostic kit for cancer |
| 02/14/1990 | EP0354729A2 Cytotoxic drug conjugates |
| 02/14/1990 | EP0354727A2 Novel single stranded phasmid vectors and methods for transforming streptomyces and other actinomycetes |
| 02/14/1990 | EP0354641A2 Recombinant DNA encoding a 4''-0-isovaleryl acylase |
| 02/14/1990 | EP0354624A2 A method for identifying and using biosynthetic or regulatory genes for enhanced production of secondary metabolites |
| 02/14/1990 | EP0354592A1 A novel human physiologically active polypeptide |
| 02/14/1990 | EP0354580A2 HLA class I DNA, DNA probes and transformed cells |
| 02/14/1990 | EP0354551A2 Thermostable lipoprotein lipase, process for producng the same, and triglyceride determining reagent using the same |
| 02/14/1990 | EP0354529A2 Chiral hydroxycarboxylic acids from prochiral diols |
| 02/14/1990 | EP0354491A2 Nematicidal microorganisms, their isolation and their use as bionemacides |
| 02/14/1990 | EP0354408A1 Anti-urokinase monoclonal antibodies |
| 02/14/1990 | EP0354213A1 Transgenic animal cells resistant to viral infection |
| 02/14/1990 | CN1039617A New antitumor medicament obtained by stereospecific reduction of 4'-deoxy-4'iododoxorubicin microbe |
| 02/14/1990 | CN1039616A Pichia pastoris alcohol oxidase ii regulatory region |
| 02/14/1990 | CN1006808B Purification of lipotropic protein produced by pichia yeast |
| 02/13/1990 | US4900673 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
| 02/13/1990 | US4900672 Method for preservation of nitrile hydration activity |
| 02/13/1990 | US4900668 Preparation of pyruvic acid |
| 02/13/1990 | US4900661 Method for immunological determination of amines, monoclonal antibodies and kit of reagents for carrying out the method |
| 02/13/1990 | US4900659 Nucleotide sequence composition and method for detection of Neisseria gonorrhoeae and method for screening for a nucleotide sequence that is specific for a genetically distinct group |
| 02/13/1990 | CA1265757A1 Process for the production of l-carnitine by way of microbiology |
| 02/08/1990 | WO1990001069A1 Process for amplifying and detecting nucleic acid sequences |
| 02/08/1990 | WO1990001066A1 Porcine polyclonal and monoclonal antibodies |
| 02/08/1990 | WO1990001063A1 New secretory leader sequences |
| 02/08/1990 | WO1990001060A1 Low molecular weight xylanase glycoprotein |
| 02/08/1990 | WO1990001039A1 Nonglycosylated human interleukin-3 compositions |
| 02/08/1990 | WO1990001038A1 Human insulin analogs and preparations containing them |
| 02/08/1990 | WO1990000902A1 Monoclonal antibodies reactive with cachectin |
| 02/08/1990 | WO1989009788A3 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 02/08/1990 | WO1989009787A3 Osteogenic devices |
| 02/07/1990 | EP0354109A1 Recombinant HBsAg hybrid particles having morphological characteristics of the HBsAg antigen and containing an immunogenic sequence which induces neutralizing antibodies directed against HIV or susceptible of being recognized by such antibodies. Nucleotide sequences coding for such particles and vaccines containing them |
| 02/07/1990 | EP0354072A1 Precursors of the HIV-2 retrovirus envelope glycoprotein and related antigens |
| 02/07/1990 | EP0353938A1 Process for producing neuraminidase |
| 02/07/1990 | EP0353910A2 Human interferon-gamma, process for preparing said human interferon-gamma, and its use |
| 02/07/1990 | EP0353908A2 DNA constructs and plant incorporating them |
| 02/07/1990 | EP0353851A1 Fowlpox virus non-essential regions |
| 02/07/1990 | EP0353827A2 New immunosuppressant-producing culture |
| 02/07/1990 | EP0353814A2 Synthetic peptide endowed with immunological activity, capable of inducing the production of antibodies with a high specificity towards alpha-fetoprotein, and their use in the diagnostic field |
| 02/07/1990 | EP0353812A2 A process for the rescue of DNA and for detecting mutations in marker genes |
| 02/07/1990 | EP0353809A1 Pseudorabies virus vaccine |
| 02/07/1990 | EP0353689A2 Method of controlling foliar diseases caused by fungal pathogens with fungicidal bacteria and novel pure cultures of fungicidal bacteria |
| 02/07/1990 | EP0353683A2 Bioconversion |
| 02/07/1990 | EP0353678A2 FR-901154 and FR-901155 substances, a process for their production |
| 02/07/1990 | EP0353581A2 Pharmaceutical compositions comprising selected lactobacillus strains |
| 02/07/1990 | EP0353516A2 A method for the preparation of recombinant human beta interleukin-1 in the homogeneous form |
| 02/07/1990 | EP0353381A2 Antibiotic LL-E19085 Alpha |
| 02/07/1990 | EP0353342A1 Low molecular weight xylanase glycoprotein |
| 02/07/1990 | EP0353250A1 The engineering of electrostatic interactions at metal ion binding sites for the stabilization of proteins |
| 02/07/1990 | CN1039442A Process for producing l-glutamic acid |
| 02/06/1990 | US4898931 Novel human interferon-γ polypeptide derivative |
| 02/06/1990 | US4898821 Cultivation of streptomyces |
| 02/06/1990 | CA1265650A1 Method for purifying a physiologically active substance produced by recombinant dna technique |
| 02/06/1990 | CA1265462A1 Antibiotic a42125 and process for its production |
| 01/31/1990 | EP0353188A2 Novel expression system |
| 01/31/1990 | EP0353150A1 Recombinant non-glycosylated human IL2 in reduced form, process for its production and its medical use |
| 01/31/1990 | EP0353145A1 Polysaccharides, process for their preparation by cultivating Pseudomonas paucimobilis, and use of the strains in agriculture |
| 01/31/1990 | EP0353049A2 NAD-independent alpha- glycerol-3-phosphate dehydrogenases, production and use therof in triglyceride and glycerol determinations |
| 01/31/1990 | EP0352839A2 Process for producing hEGF |
| 01/31/1990 | EP0352784A2 Gamma-glutamyl cystein transferase, process for its production and use of same |
| 01/31/1990 | EP0352761A2 Antigens composed of "major histocompatibility complex" class I antigens and specific carrier molecules, their production and use |
| 01/31/1990 | EP0352707A2 An expression system for the secretion of bioactive human granulocyte macrophage colony stimulating factor (GM-CSF) and other heterologous proteins from streptomyces |
| 01/31/1990 | EP0352651A1 Human protein C mutants and method for preparing the same |
| 01/31/1990 | EP0352646A2 FR901228 Substance and preparation thereof |
| 01/31/1990 | EP0352538A2 Amides of N15-alkyl and N15,N15-dialkyl teicoplanin derivatives |
| 01/31/1990 | EP0352474A2 Thermostable glucose isomerase |
| 01/31/1990 | EP0352387A1 Method for preparing a hirudin |
| 01/31/1990 | EP0352328A1 Human monoclonal antibody against aspergilli |
| 01/31/1990 | EP0352299A1 Rubradirin derivatives for treatment of hiv infection |
| 01/31/1990 | EP0154646B1 A method for the conversion of a cellulosic substrate to glucose using microbispora bispora, strain rutgers p&w |
| 01/30/1990 | US4897471 Consensus human leukocyte interferon |
| 01/30/1990 | US4897470 Anthracycline antibiotics DCP-1 and 2 |
| 01/30/1990 | US4897351 Process of selective bioconversion of isosorbitol dinitrate |
| 01/30/1990 | US4897349 Aerobic cultivation of microorganism, s. zooepidemicus; controlling oxygen |
| 01/30/1990 | US4897264 Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody |
| 01/30/1990 | US4897104 Cornexistin; plant growth regulators |
| 01/30/1990 | CA1265082A1 Analog enrichment decontamination process |
| 01/26/1990 | EP0362298A4 Novel polypeptide having gamma-interferon activity. |
| 01/25/1990 | WO1990000624A1 Antisense oligonucleotide antibiotics complementary to the macromolecular synthesis operon, methods of treating bacterial infections and methods for identification of bacteria |
| 01/25/1990 | WO1990000617A1 Antibodies specific towards gp 48 |
| 01/25/1990 | WO1990000612A1 Production of chemical compounds |
| 01/25/1990 | WO1990000610A1 New expression vectors |
| 01/25/1990 | WO1990000609A1 Cellulose binding fusion proteins |
| 01/25/1990 | WO1990000606A1 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response |
| 01/25/1990 | WO1990000605A1 Methods and means for controlling the stability of proteins |
| 01/25/1990 | WO1990000604A1 Transformed shigella |
| 01/25/1990 | WO1990000594A2 Recombinant mycobacterial expression vehicles and uses therefor |
| 01/25/1990 | WO1990000567A1 A migration stimulating factor |
| 01/25/1990 | WO1990000565A1 Interleukin ii analogs |
| 01/25/1990 | WO1990000563A1 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human |
| 01/25/1990 | WO1990000558A1 Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor |
| 01/25/1990 | WO1990000556A1 Synthetic hiv protease gene and method for its expression |
| 01/25/1990 | WO1990000403A1 Genetically engineered coccidiosis vaccine |
| 01/25/1990 | WO1990000400A1 Tumor necrosis enhancing factor and methods of preparation and use |
| 01/25/1990 | WO1990000352A1 Method of obtaining a bacterial ferment for medical-dietetic product |
| 01/24/1990 | EP0352250A2 Bordetella pertussis vaccine |
| 01/24/1990 | EP0352228A2 Novel proteins |
| 01/24/1990 | EP0352227A2 Modified proteins |